Intravitreal and posterior subtenon triamcinolone acetonide for severe acute posterior multifocal placoid pigment epitheliopathy.
Anti-Inflammatory Agents
/ administration & dosage
Fluorescein Angiography
Humans
Intravitreal Injections
/ methods
Male
Tenon Capsule
Time Factors
Tomography, Optical Coherence
/ methods
Treatment Outcome
Triamcinolone Acetonide
/ administration & dosage
Visual Acuity
White Dot Syndromes
/ diagnostic imaging
Young Adult
Journal
Arquivos brasileiros de oftalmologia
ISSN: 1678-2925
Titre abrégé: Arq Bras Oftalmol
Pays: Brazil
ID NLM: 0400645
Informations de publication
Date de publication:
Historique:
received:
24
07
2018
accepted:
24
11
2018
pubmed:
28
3
2019
medline:
10
1
2020
entrez:
28
3
2019
Statut:
ppublish
Résumé
A 21-year-old man presented with visual acuity of 20/200 in both eyes. The fundus picture, fluorescein angiography, and optical coherence tomography revealed severe bilateral acute posterior multifocal placoid pigment epitheliopathy and serous macular detachments. We treated the patient with triamcinolone acetonide, an intravitreal injection (4 mg/0.1 mL) in one eye and a posterior subtenon injection (40 mg/1 mL) in the other eye. Within 2 weeks the visual acuity was 20/80 in both eyes. At the 8-week follow-up visit his vision was 20/63 bilaterally. One year later the vision remained 20/63 in both eyes. In this patient, the triamcinolone acetonide injections, whether administered intravitreally or via the posterior subtenon route, achieved similar anatomic and functional recovery results.
Identifiants
pubmed: 30916213
pii: S0004-27492019005001101
doi: 10.5935/0004-2749.20190045
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Triamcinolone Acetonide
F446C597KA
Types de publication
Case Reports
Letter
Langues
eng
Sous-ensembles de citation
IM